Financials
Income statement
| Fiscal date | Dec 2024 | Sep 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|
| Total reported revenue | 12.1B | 26.5B | 37.1B | 38.3B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 1.3B | 1.2B | 1.2B | 1.2B |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 1.0B | 1.0B | 960M | 971M |
| Other income expense | 2.8B | 2.5B | 2.3B | 2.4B |
| Pretax income | 1.9B | 1.2B | 1.1B | 964M |
| Tax provision | 511M | 135M | 180M | 27M |
| Net income | 1.3B | 1.1B | 905M | 937M |
| Basic EPS | 3.1 | 2.5 | 2.0 | 2.1 |
| Diluted EPS | 3.1 | 2.5 | 2.0 | 2.1 |
| Basic average shares | 435.5M | 436.4M | 446.2M | 451.0M |
| Diluted average shares | 435.5M | 436.4M | 446.2M | 451.0M |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | 1M | — | — | — |
| Preferred stock dividends | 7M | 7M | 8M | 8M |